Hashimoto, Kenji http://orcid.org/0000-0002-8892-0439
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H02846, 23K17634)
Article History
Received: 15 December 2023
Accepted: 22 January 2024
First Online: 27 February 2024
Declarations
:
: Dr. Hashimoto serves as one of the editors of this journal. Dr. Hashimoto is the inventor of filed patent applications on “The use of <i>R</i>-Ketamine in the treatment of psychiatric diseases,” “(<i>S</i>)-norketamine and salt thereof as pharmaceutical,” “<i>R</i>-Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder,” “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases,” and “<i>R</i>-Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. Dr. Hashimoto has also received speakers’ honoraria, consultant fee, or research support from Abbott, Boehringer-Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm, and Perception Neuroscience.